Hypothesis: A simple algorithm to distinguish between hypoaldosteronism and renal aldosterone resistance in patients with persistent hyperkalemia

Nephrology

Volumn 13, Issue 6, 2008, Pages 459-464

  Adam, William R ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Aldosterone; Hyperkalemia; Hypoaldosteronism; Potassium; Pseudohypoaldosteronism

Indexed keywords

ALDOSTERONE;

ALDOSTERONE BLOOD LEVEL; ARTICLE; CATION EXCHANGE; CONSERVATIVE TREATMENT; GLOMERULUS FILTRATION; HYPERKALEMIA; HYPOALDOSTERONISM; KIDNEY FAILURE; POTASSIUM BLOOD LEVEL; PRIORITY JOURNAL; PSEUDOHYPOALDOSTERONISM;

ALDOSTERONE; ALGORITHMS; GLOMERULAR FILTRATION RATE; HUMANS; HYPERKALEMIA; HYPOALDOSTERONISM; KIDNEY; POTASSIUM;

EID: 52649160189     PISSN: 13205358     EISSN: 14401797     Source Type: Journal    
DOI: 10.1111/j.1440-1797.2008.00962.x     Document Type: Article

References (43)

1. Defronzo RA, Bia M, Smith D. Clinical disorders of hyperkalemia. Annu. Rev. Med. 1982 33:521 54.
2. Halperin ML, Kamel KS. Potassium. Lancet 1998 352:135 40.
3. Schambelan M, Sebastian A, Rector FC Jr. Mineralocorticoid-resistant renal hyperkalemia without salt wasting (type II pseudohypoaldosteronism): Role of increased renal chloride reabsorption. Kidney Int. 1981 19:716 27.
4. Geller DS. Mineralocorticoid resistance. Clin. Endocrinol. 2005 62:513 20.
5. Arruda JA, Batlle DC, Sehy JT, Roseman MK, Baronowski RL, Kurtzman NA. Hyperkalemia and renal insufficiency: Role of selective aldosterone deficiency and tubular unresponsiveness to aldosterone. Am. J. Nephrol. 1981 1:160 7.
6. Spat A, Hunyady L. Control of aldosterone secretion: A model for convergence in cellular signaling pathways. Physiol. Rev. 2004 84:489 539.
7. Dluhy RG, Axelrod L, Underwood RH, Williams GH. Studies of the control of plasma aldosterone concentration in normal man. II. Effect of dietary potassium and acute potassium infusion. J. Clin. Invest. 1972 51:1950 7.
8. Chan R, Sealey JE, Michelis MF et al. Renin-aldosterone system can respond to furosemide in patients with hyperkalemic hyporeninism. J. Lab. Clin. Med. 1998 132:229 35.
9. Christlieb AR, Kaldany A, D'Elia JA, Williams GH. Aldosterone responsiveness in patients with diabetes mellitus. Diabetes 1978 27:732 7.
10. Cosgriff TM, Olin DB, Nash DA Jr. Hyporeninemic hypoaldosteronism - case report and observation of dissociated renin and erythropoietin activity. J. Chronic Dis. 1978 31:195 200.
11. Don BR, Schambelan M. Hyperkalemia in acute glomerulonephritis due to transient hyporeninemic hypoaldosteronism. Kidney Int. 1990 38:1159 63.
12. Manser TJ, Estep H. Pseudo-Addison's disease. Isolated corticotropin deficiency associated with hyporeninemic hypoaldosteronism. Arch. Intern. Med. 1986 146:996 7.
13. Pelleya R, Oster JR, Perez GO. Hyporeninemic hypoaldosteronism, sodium wasting and mineralocorticoid-resistant hyperkalemia in two patients with obstructive uropathy. Am. J. Nephrol. 1983 3:223 7.
14. Rado JP, Simatupang T, Boer P, Mees EJ. Increase of serum potassium in the upright posture in selective hypoaldosteronism. Horm. Metab. Res. 1979 11:47 51.
15. Rosler A, Theodor R, Gazit E, Biochis H, Rabinowitz D. Salt wasting, raised plasma-renin activity, and normal or high plasma-aldosterone: A form of pseudohypoaldosteronism. Lancet 1973 1:959 62.
16. Sakemi T, Ohchi N, Sanai T, Rikitake O, Maeda T. Captopril-induced metabolic acidosis with hyperkalemia. Am. J. Nephrol. 1988 8:245 8.
17. Schambelan M, Sebastian A, Biglieri EG. Prevalence, pathogenesis, and functional significance of aldosterone deficiency in hyperkalemic patients with chronic renal insufficiency. Kidney Int. 1980 17:89 101.
18. Shiah CJ, Wu KD, Tsai DM, Liao ST, Siauw CP, Lee LS. Diagnostic value of plasma aldosterone/potassium ratio in hypoaldosteronism. J. Formos Med. Assoc. 1995 94:248 54.
19. Textor SC, Bravo EL, Fouad FM, Tarazi RC. Hyperkalemia in azotemic patients during angiotensin-converting enzyme inhibition and aldosterone reduction with captopril. Am. J. Med. 1982 73:719 25.
20. Touger L, Joseph M, Hasan KS. Hypertension in a patient with aldosterone deficiency. Endocr. Pract. 2005 11:104 7.
21. Watanabe T, Nitta K. Transient hyporeninemic hypoaldosteronism in acute glomerulonephritis. Pediatr. Nephrol. 2002 17:959 63.
22. Claris AA, Marra G, Tirelli SA et al. Early childhood hyperkalemia: Variety of pseudohypoaldosteronism. Acta Paediatr. Scand. 1986 75:970 4.
23. Sauder SE, Kelch RP, Grekin RJ, Kelsch RC. Suppression of plasma renin activity in a boy with chronic hyperkalemia. Am. J. Dis. Child 1987 141:922 7.
24. Brautbar N, Levi J, Rosler A et al. Familial hyperkalemia, hypertension, and hyporeninemia with normal aldosterone levels. A tubular defect in potassium handling. Arch. Intern. Med. 1978 138:607 10.
25. DeFronzo RA, Cooke CR, Goldberg M, Cox M, Myers AR, Agus ZS. Impaired renal tubular potassium secretion in systemic lupus erythematosus. Ann. Intern. Med. 1977 86:268 71.
26. Farfel Z, Iaina A, Rosenthal T, Waks U, Shibolet S, Gafni J. Familial hyperpotassemia and hypertension accompanied by normal plasma aldosterone levels: Possible hereditary cell membrane defect. Arch. Intern. Med. 1978 138:1828 32.
27. Fortini A, Nenci G, Laureano R, Cappelletti C. Hypertension, hyperpotassemia and normal glomerular filtration (Gordon's syndrome): A case report G Ital Cardiol 1996 26:51 6.
28. Isenring P, Lebel M, Grose JH. Endocrine sodium and volume regulation in familial hyperkalemia with hypertension. Hypertension 1992 19:371 7.
29. Lee MR, Ball SG, Thomas TH, Morgan DB. Hypertension and hyperkalaemia responding to bendrofluazide. Q. J. Med. 1979 48:245 58.
30. Muhammad S, Mamish ZM, Tucci JR. Type II pseudohypoaldosteronism. Report of a case and review of the literature. J. Endocrinol. Invest. 1994 17:453 7.
31. Nahum H, Paillard M, Prigent A et al. Pseudohypoaldosteronism type II: Proximal renal tubular acidosis and dDAVP-sensitive renal hyperkalemia. Am. J. Nephrol. 1986 6:253 62.
32. Rado JP, Boer P, Dorhout Mees EJ, Simatupang T. Outpatient hyperkalemia' syndrome in renal and hypertensive patients with suppressed aldosterone production. J. Med. 1979 10:145 57.
33. Shoker A, Morris G, Skomro R, Laxdal V. Pseudohypoaldosteronism with normal blood pressure. Clin. Nephrol. 1996 46:105 11.
34. Stokes GS, Gentle JL, Edwards KD, Stewart JH. Syndrome of idiopathic hyperkalaemia and hypertension with decreased plasma renin activity: Effects on plasma renin and aldosterone of reducing the serum potassium level. Med. J. Aust. 1968 2:1050 4.
35. Szylman P, Wolach B, Winaver J et al. Nonazotemic hyperkalemia with renal and extrarenal defects in potassium transport: Association with high levels of digoxin-like immunoreactive factor. J. Lab. Clin. Med. 1990 116:315 26.
36. Throckmorton DC, Bia MJ. Pseudohypoaldosteronism: Case report and discussion of the syndrome. Yale J. Biol. Med. 1991 64:247 54.
37. Weinstein SF, Allan DM, Mendoza SA. Hyperkalemia, acidosis, and short stature associated with a defect in renal potassium excretion. J. Pediatr. 1974 85:355 8.
38. Vantyghem MC, Hober C, Evrard A et al. Transient pseudo-hypoaldosteronism following resection of the ileum: Normal level of lymphocytic aldosterone receptors outside the acute phase. J. Endocrinol. Invest. 1999 22:122 7.
39. Yeap BB, Platlell CF, Ferrari P. Apparent addison's disease following ileostomy. Nephrology (Carlton) 2005 10:537 8.
40. Weidmann P, Maxwell MH, Rowe P, Winer R, Massry SG. Role of the renin-angiotensin-aldosterone system in the regulation of plasma potassium in chronic renal disease. Nephron 1974 15:35 49.
41. Donohoo E ed. MIMS, 3rd Issue. Sydney:CMP Medica Australia, 2007.
42. Hussein RM, McIntosh SH, Lawson J, Kenny RA. Fludrocortisone in the treatment of hypotensive disorders in the elderly. Heart 1996 76:507 9.
43. Ponda MP, Hostetter TH. Aldosterone antagonism in chronic kidney disease. Clin. J. Am. Soc. Nephrol. 2006 1:668 77.